DGIdb - COCAINE Drug Record

COCAINE chembl:CHEMBL370805 Approved

Alternate Names:

RX-0041
RX0041
COCAINE
IDS-NC-004
BETA-COCAIN
KOKAIN
(-)-COCAINE
METHYL [1R-(EXO,EXO)]-3-(BENZOYLOXY)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE
COCAINUM
L-COCAIN
METHYL BENZOYLECGONINE
BENZOYLMETHYLECGONINE
2-METHYL-3BETA-HYDROXY-1ALPHAH,5ALPHAH-TROPANE-2BETA-CARBOXYLATE BENZOATE (ESTER)
[1R-(EXO,EXO)]-3-(BENZOYLOXY)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID, METHYL ESTER
NEUROCAINE
L-COCAINE
COCAINA
(−)-COCAINE
COCAIN
chembl:CHEMBL370805
drugbank:00907
rxcui:2653
pubchem.compound:446220
chemidplus:50-36-2

Drug Info:

FDA Approval	Approved before 1982
Drug Class	small molecule
Drug Indications	local anesthetic
Year of Approval	approved before 1982
Drug Class	anesthetics, local
Drug Categories	anesthetics, local
Drug Categories	agents producing tachycardia
Drug Categories	agents that reduce seizure threshold
Drug Categories	anticholinergic agents
Drug Categories	cholinesterase substrates
Drug Categories	cocaine, antagonists & inhibitors
Drug Categories	cytochrome p-450 cyp2d6 inhibitors (strength unknown)
Drug Categories	cytochrome p-450 cyp3a substrates
Drug Categories	cytochrome p-450 enzyme inhibitors
Drug Categories	cytochrome p-450 substrates
Drug Categories	esters of benzoic acid
Drug Categories	highest risk qtc-prolonging agents
Drug Categories	muscarinic antagonists
Drug Categories	nervous system
Drug Categories	oct2 inhibitors
Drug Categories	ophthalmologicals
Drug Categories	qtc prolonging agents
Drug Categories	serotonergic drugs shown to increase risk of serotonin syndrome
Drug Categories	throat preparations

(2 More Sources)

Publications:

Corey et al., 1994, A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization., Proc. Natl. Acad. Sci. U.S.A.
Carrera et al., 2004, Cocaine pharmacology and current pharmacotherapies for its abuse., Bioorg. Med. Chem.
Patkar et al., 2002, Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals., Psychiatry Res
Tatsumi et al., 1997, Pharmacological profile of antidepressants and related compounds at human monoamine transporters., Eur. J. Pharmacol.
Barker et al., 1999, Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter., J. Neurosci.
Galli et al., 1995, Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants., J. Exp. Biol.
Burchett et al., 1997, Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration., Brain Res. Mol. Brain Res.
Zhao et al., Perinatal cocaine exposure reduces myocardial norepinephrine transporter function in the neonatal rat., Neurotoxicol Teratol
Antzelevitch, 2006, Brugada syndrome., Pacing Clin Electrophysiol
Wright et al., 1999, State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit., Biophys. J.
Satish et al., 2005, Brugada syndrome--an update., Chang Gung Med J
Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
Negrão AB et al., 2013, Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes., PLoS One
Wilson et al., 1996, Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users., Ann. Neurol.
Rothman et al., 1999, Discovery of novel peptidic dopamine transporter ligands by screening a positional scanning combinatorial hexapeptide library., Synapse
Kim et al., 2003, Synthesis and pharmacology of site specific cocaine abuse treatment agents: 8-substituted isotropane (3-azabicyclo[3.2.1]octane) dopamine uptake inhibitors., J. Med. Chem.
Verma V, 2015, Classic Studies on the Interaction of Cocaine and the Dopamine Transporter., Clin Psychopharmacol Neurosci
Schinka JA et al., 2002, A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances., Mol Psychiatry
Arias A et al., 2006, Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis., Drug Alcohol Depend
Türkan H et al., 2019, The association between the OPRM1 A118G polymorphism and addiction in a Turkish population., Arh Hig Rada Toksikol
Sharkey et al., 1988, Cocaine inhibits muscarinic cholinergic receptors in heart and brain., J. Pharmacol. Exp. Ther.
Rendic S et al., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors., Drug Metab Rev
Aroche AP et al., 2020, Association of CHRNA5 Gene Variants with Crack Cocaine Addiction., Neuromolecular Med
da Silva BS et al., 2019, The association between SYT1-rs2251214 and cocaine use disorder further supports its role in psychiatry., Prog Neuropsychopharmacol Biol Psychiatry
Brzezinski MR et al., 1997, Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs., Drug Metab Dispos
Crumb WJ Jr et al., 1990, Characterization of cocaine-induced block of cardiac sodium channels., Biophys J
Yasui Y et al., 2016, Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine., J Drug Alcohol Res
Narayanan S et al., 2011, Sigma receptors and cocaine abuse., Curr Top Med Chem
Navarro G et al., 2010, Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine., Proc Natl Acad Sci U S A

COCAINE SYT1

Interaction Score: 4.37

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
31059723

Sources:
PharmGKB
COCAINE CHRNA5

Interaction Score: 0.87

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
32152934

Sources:
PharmGKB
COCAINE SIGMAR1

Interaction Score: 0.5

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
27088037 21050176 3047364 20956312

Sources:
DrugBank
COCAINE SLC6A1

Interaction Score: 0.36

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TEND
COCAINE SLC6A3

Interaction Score: 0.29

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
8797532 10420171 12672245 15351386 9537821 26598579

Sources:
TEND PharmGKB TdgClinicalTrial TTD DrugBank
COCAINE SLC6A4

Interaction Score: 0.2

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
8302852 15351386 12057823 9537821 10366604

Sources:
TEND TdgClinicalTrial DrugBank
COCAINE SLC6A2

Interaction Score: 0.2

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
7500004 15351386 9387868 15113605

Sources:
TEND TdgClinicalTrial DrugBank
COCAINE CES1

Interaction Score: 0.18

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9311626

Sources:
DrugBank
COCAINE CHRNA3

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
32152934

Sources:
PharmGKB
COCAINE SCN11A

Interaction Score: 0.15

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
17139284 17016423

Sources:
TEND TdgClinicalTrial
COCAINE KAT2B

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
COCAINE SCN5A

Interaction Score: 0.14

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
17038146 9876137 15880981

Sources:
TEND PharmGKB TdgClinicalTrial
COCAINE BCHE

Interaction Score: 0.12

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
24312228

Sources:
PharmGKB
COCAINE SCN10A

Interaction Score: 0.11

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
17139284 17016423

Sources:
TEND TdgClinicalTrial
COCAINE SCN1A

Interaction Score: 0.09

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
2155033 9876137

Sources:
DrugBank
COCAINE OPRM1

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11840318 16387451 31246565

Sources:
PharmGKB
COCAINE CHRM2

Interaction Score: 0.05

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
3047364 15351386

Sources:
DrugBank
COCAINE CNR1

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
COCAINE DRD3

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
None found

Sources:
TEND TdgClinicalTrial
COCAINE CHRM1

Interaction Score: 0.04

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

PMIDs:
3047364 15351386

Sources:
DrugBank
COCAINE OPRK1

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
None found

Sources:
TEND TdgClinicalTrial
COCAINE OPRD1

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
COCAINE GABRA2

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
COCAINE DRD1

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TEND
COCAINE DRD2

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
COCAINE CYP3A4

Interaction Score: 0.0

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9187528

Sources:
PharmGKB

DrugBank: DB00907

Version: 5.1.7

Alternate Names:

50-36-2 CAS Number

Cocaine Hydrochloride Drug Brand

Cocaine Hydrochloride Top Sol 40mg/ml Drug Brand

Drug Info:

Drug Type small molecule

Drug Groups approved

Drug Groups illicit

Publications:

Brzezinski MR et al., 1997, Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs., Drug Metab Dispos

Crumb WJ Jr et al., 1990, Characterization of cocaine-induced block of cardiac sodium channels., Biophys J

Wright et al., 1999, State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit., Biophys. J.

TdgClinicalTrial: COCAINE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications local anesthetic

Drug Class small molecule

FDA Approval Approved before 1982

Publications:
TEND: COCAINE
- Version: 01-August-2011
Alternate Names:

Drug Info:

Drug Class anesthetics, local

Year of Approval approved before 1982

Publications:

PharmGKB: cocaine

Version: 18-August-2020

Alternate Names:

Drug Info:

Publications:

Aroche AP et al., 2020, Association of CHRNA5 Gene Variants with Crack Cocaine Addiction., Neuromolecular Med

Negrão AB et al., 2013, Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes., PLoS One

Schinka JA et al., 2002, A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances., Mol Psychiatry

TTD: Cocaine
- Version: 2020.06.01
Alternate Names:

D04XPW TTD Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL370805
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

50-36-2	CAS Number
Cocaine Hydrochloride	Drug Brand
Cocaine Hydrochloride Top Sol 40mg/ml	Drug Brand

Drug Type	small molecule
Drug Groups	approved
Drug Groups	illicit

Trial Name	-
Novel drug target	Established target

Trial Name	-
Novel drug target	Established target

Trial Name	-
Novel drug target	Established target

Trial Name	-
Novel drug target	Established target

COCAINE Drug Record

COCAINE chembl:CHEMBL370805 Approved

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 31059723

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 32152934

Sources: PharmGKB

Interaction Types & Directionality: agonist (activating)

Interaction Info:

PMIDs: 27088037 21050176 3047364 20956312

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: TEND

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 8797532 10420171 12672245 15351386 9537821 26598579

Sources: TEND PharmGKB TdgClinicalTrial TTD DrugBank

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 8302852 15351386 12057823 9537821 10366604

Sources: TEND TdgClinicalTrial DrugBank

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 7500004 15351386 9387868 15113605

Sources: TEND TdgClinicalTrial DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 9311626

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 32152934

Sources: PharmGKB

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 17139284 17016423

Sources: TEND TdgClinicalTrial

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: PharmGKB

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 17038146 9876137 15880981

Sources: TEND PharmGKB TdgClinicalTrial

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 24312228

Sources: PharmGKB

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Novel drug target Established target Trial Name -

PMIDs: 17139284 17016423

Sources: TEND TdgClinicalTrial

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info:

PMIDs: 2155033 9876137

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 11840318 16387451 31246565

Sources: PharmGKB

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info:

PMIDs: 3047364 15351386

Sources: DrugBank

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info: Novel drug target Established target Trial Name -

PMIDs: None found

Interaction Types & Directionality:

n/a

PMIDs:
31059723

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
32152934

Sources:
PharmGKB

Interaction Types & Directionality:

agonist (activating)

PMIDs:
27088037 21050176 3047364 20956312

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TEND

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
8797532 10420171 12672245 15351386 9537821 26598579

Sources:
TEND PharmGKB TdgClinicalTrial TTD DrugBank

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
8302852 15351386 12057823 9537821 10366604

Sources:
TEND TdgClinicalTrial DrugBank

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
7500004 15351386 9387868 15113605

Sources:
TEND TdgClinicalTrial DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
9311626

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
32152934

Sources:
PharmGKB

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
17139284 17016423

Sources:
TEND TdgClinicalTrial

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
17038146 9876137 15880981

Sources:
TEND PharmGKB TdgClinicalTrial

Interaction Types & Directionality:

n/a

PMIDs:
24312228

Sources:
PharmGKB

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
17139284 17016423

Sources:
TEND TdgClinicalTrial

Interaction Types & Directionality:

inhibitor (inhibitory)

PMIDs:
2155033 9876137

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
11840318 16387451 31246565

Sources:
PharmGKB

Interaction Types & Directionality:

antagonist (inhibitory)

PMIDs:
3047364 15351386

Sources:
DrugBank

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
None found

Sources:
TEND TdgClinicalTrial

Interaction Types & Directionality:

antagonist (inhibitory)

PMIDs:
3047364 15351386

Sources:
DrugBank

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
None found

Sources:
TEND TdgClinicalTrial

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TEND